What is a common loading dose range for clopidogrel when ACS patients undergo PCI?

Prepare for the ACLS ProMed exam with our comprehensive questions and detailed explanations. Enhance your skills with targeted flashcards and multiple-choice questions designed to optimize your study time.

Multiple Choice

What is a common loading dose range for clopidogrel when ACS patients undergo PCI?

Explanation:
When treating ACS patients undergoing PCI, the goal is to rapidly inhibit platelet aggregation by blocking the P2Y12 receptor, since clopidogrel is a prodrug that takes time to convert to its active form. A loading dose is used to achieve this quickly. The common range is 300 to 600 mg because 300 mg provides a solid, effective onset of platelet inhibition, while 600 mg speeds and intensifies the effect for faster protection during urgent or high-risk PCI. After the loading dose, a maintenance dose of 75 mg daily is used to sustain antiplatelet effect. The other options don’t fit: a maintenance dose of 75 mg is not a loading dose, a very small 10 mg dose won’t provide meaningful inhibition, and 1200 mg is not standard practice due to diminishing returns and increased bleeding risk.

When treating ACS patients undergoing PCI, the goal is to rapidly inhibit platelet aggregation by blocking the P2Y12 receptor, since clopidogrel is a prodrug that takes time to convert to its active form. A loading dose is used to achieve this quickly. The common range is 300 to 600 mg because 300 mg provides a solid, effective onset of platelet inhibition, while 600 mg speeds and intensifies the effect for faster protection during urgent or high-risk PCI. After the loading dose, a maintenance dose of 75 mg daily is used to sustain antiplatelet effect.

The other options don’t fit: a maintenance dose of 75 mg is not a loading dose, a very small 10 mg dose won’t provide meaningful inhibition, and 1200 mg is not standard practice due to diminishing returns and increased bleeding risk.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy